JAK Inhibitor Safety and Efficacy in 2025

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/6f/49/54/6f4954cf-000e-ce38-f353-be4d20e14c1a/mza_815154795610997381.jpg/600x600bb.jpg

Science for the Real World: Canadian IBD Today

Catalytic Health

2 episodes

1 week ago

The aim of Canadian IBD Today is to provide perspective and insight on the management of common diseases and disorders in IBD and to provide a forum for clinicians to share their real-world experiences in practice.

Medicine

Health & Fitness

RSS

All content for Science for the Real World: Canadian IBD Today is the property of Catalytic Health and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/41879440/41879440-1724346183865-574e13d15aa9e.jpg

JAK Inhibitor Safety and Efficacy in 2025

Science for the Real World: Canadian IBD Today

25 minutes 36 seconds

8 months ago

JAK Inhibitor Safety and Efficacy in 2025

Dr. Brian Bressler speaks with Dr. Neeraj Narula and Dr. Cynthia Seow about JAK inhibitor safety and efficacy in 2025. This episode of Science for the Real World is part of ⁠Canadian IBD Today⁠, an open access scientific journal for the gastroenterology community.